Triptolide prevents bone loss via suppressing osteoclastogenesis through inhibiting PI3K‐AKT‐NFATc1 pathway

Bone loss (osteopenia) is a common complication in human solid tumour. In addition, after surgical treatment of gynaecological tumour, osteoporosis often occurs due to the withdrawal of oestrogen. The major characteristic of osteoporosis is the low bone mass with micro‐architectural deteriorated bon...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Jin, Li, Xiaoqun, Wang, Sicheng, Su, Yiming, Chen, Xiao, Cao, Liehu, Zhi, Xin, Qiu, Zili, Wang, Yao, Jiang, Hao, Huang, Biaotong, Ji, Fang, Su, Jiacan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7294126/
https://www.ncbi.nlm.nih.gov/pubmed/32347017
http://dx.doi.org/10.1111/jcmm.15229

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7294126/
https://www.ncbi.nlm.nih.gov/pubmed/32347017
http://dx.doi.org/10.1111/jcmm.15229

Ejemplares similares